Collection |
Collections
Filters
-
Collection Type
-
-
Collection |
Combating infectious diseases
We present a series of companies developing technologies, vaccines and therapeutics to prevent and treat the continuing serious threat of bacteria and viruses to human health.
Image: Samer ALMOHAMAD / Alamy Stock Photo -
Collection |
Advances in artificial intelligence-driven drug development
In this expanded collection, we present companies harnessing the power of artificial intelligence for the development of cutting-edge tools and novel approaches to accelerate drug discovery and research.
Image: Yuichiro Chino -
Collection |
Next-generation molecular diagnostics
New techniques and materials are spurring the development of next-generation molecular diagnostics, critical for disease prevention and treatment.
Image: Medicshots / Alamy Stock Photo -
Collection |
The search for rare disease therapies
Complex, genetic and rare diseases continue to pose challenges globally, but new targeted approaches and personalized therapies are accelerating progress in the field. Here we present rare diseases therapies in development.
Image: Kateryna Kon/Science Photo Library -
Collection |
Tackling antimicrobial resistance
Antimicrobial resistance remains a global health threat, in this collection we present companies developing therapeutics to urgently fight against a range of potentially dangerous pathogens.
Image: Hülya Koca / Alamy Stock Photo -
Collection |
Advances in antibody technologies
Development in antibody technologies continues to diversify, providing a rich pipeline of new and innovative therapeutics. In this collection, we present antibody-focused companies, along with their technologies and therapies.
Image: Credit: Science Picture Co / Alamy Stock Photo -
Collection |
Innovations in ophthalmology
New innovative approaches harnessing gene therapy, drug delivery and artificial intelligence are proving successful to help treat diseases of the eye.
Image: Andrey Volodin / Alamy Stock Photo -
Collection |
Artificial intelligence in drug development
From rapid candidate selection, to fewer clinical trials and faster market approval, artificial intelligence approaches are helping to accelerate and improve the efficiency of the drug development process, whilst significantly reducing costs. Here we present a number of companies working in the field.
Image: Westend61
Fighting central nervous system disorders
